TI - The Prevalence and Prognostic Relevance of ABO/Rh Blood Groups in Metastatic Breast Cancer Patients Undergoing Cyclin-Dependent Kinase 4/6 Inhibitors Therapy
PT - Journal Article
DP - 2024
TA - EJMI
PG - 212-219
VI - 8
IP - 3
AID - 2024.49619 [doi]
4100 - https://dx.doi.org/10.14744/ejmi.2024.49619
SO - EURASIAN JOURNAL OF MEDICIAL INVESTIGATION,2024 8(3): 212